Image of an eosinophil
Find information on thousands of medical conditions and prescription drugs.

Pneumonia, eosinophilic

Eosinophilic pneumonia (EP) is a disease in which a certain type of white blood cell called an eosinophil accumulates in the lung. These cells cause disruption of the normal air spaces (alveoli) where oxygen is extracted from the atmosphere. Several different kinds of eosinophilic pneumonia exist and can occur in any age group. The most common symptoms include cough, fever, difficulty breathing, and sweating at night. EP is diagnosed by a combination of characteristic symptoms, findings on a physical examination by a health provider, and the results of blood tests and x-rays. Prognosis is excellent once most EP is recognized and treatment with corticosteroids is begun. more...

Home
Diseases
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Arthritis
Arthritis
Bubonic plague
Hypokalemia
Pachydermoperiostosis
Pachygyria
Pacman syndrome
Paget's disease of bone
Paget's disease of the...
Palmoplantar Keratoderma
Pancreas divisum
Pancreatic cancer
Panhypopituitarism
Panic disorder
Panniculitis
Panophobia
Panthophobia
Papilledema
Paraganglioma
Paramyotonia congenita
Paraphilia
Paraplegia
Parapsoriasis
Parasitophobia
Parkinson's disease
Parkinson's disease
Parkinsonism
Paroxysmal nocturnal...
Patau syndrome
Patent ductus arteriosus
Pathophobia
Patterson...
Pediculosis
Pelizaeus-Merzbacher disease
Pelvic inflammatory disease
Pelvic lipomatosis
Pemphigus
Pemphigus
Pemphigus
Pendred syndrome
Periarteritis nodosa
Perinatal infections
Periodontal disease
Peripartum cardiomyopathy
Peripheral neuropathy
Peritonitis
Periventricular leukomalacia
Pernicious anemia
Perniosis
Persistent sexual arousal...
Pertussis
Pes planus
Peutz-Jeghers syndrome
Peyronie disease
Pfeiffer syndrome
Pharmacophobia
Phenylketonuria
Pheochromocytoma
Photosensitive epilepsy
Pica (disorder)
Pickardt syndrome
Pili multigemini
Pilonidal cyst
Pinta
PIRA
Pityriasis lichenoides...
Pityriasis lichenoides et...
Pityriasis rubra pilaris
Placental abruption
Pleural effusion
Pleurisy
Pleuritis
Plummer-Vinson syndrome
Pneumoconiosis
Pneumocystis jiroveci...
Pneumocystosis
Pneumonia, eosinophilic
Pneumothorax
POEMS syndrome
Poland syndrome
Poliomyelitis
Polyarteritis nodosa
Polyarthritis
Polychondritis
Polycystic kidney disease
Polycystic ovarian syndrome
Polycythemia vera
Polydactyly
Polymyalgia rheumatica
Polymyositis
Polyostotic fibrous...
Pompe's disease
Popliteal pterygium syndrome
Porencephaly
Porphyria
Porphyria cutanea tarda
Portal hypertension
Portal vein thrombosis
Post Polio syndrome
Post-traumatic stress...
Postural hypotension
Potophobia
Poxviridae disease
Prader-Willi syndrome
Precocious puberty
Preeclampsia
Premature aging
Premenstrual dysphoric...
Presbycusis
Primary biliary cirrhosis
Primary ciliary dyskinesia
Primary hyperparathyroidism
Primary lateral sclerosis
Primary progressive aphasia
Primary pulmonary...
Primary sclerosing...
Prinzmetal's variant angina
Proconvertin deficiency,...
Proctitis
Progeria
Progressive external...
Progressive multifocal...
Progressive supranuclear...
Prostatitis
Protein S deficiency
Protein-energy malnutrition
Proteus syndrome
Prune belly syndrome
Pseudocholinesterase...
Pseudogout
Pseudohermaphroditism
Pseudohypoparathyroidism
Pseudomyxoma peritonei
Pseudotumor cerebri
Pseudovaginal...
Pseudoxanthoma elasticum
Psittacosis
Psoriasis
Psychogenic polydipsia
Psychophysiologic Disorders
Pterygium
Ptosis
Pubic lice
Puerperal fever
Pulmonary alveolar...
Pulmonary hypertension
Pulmonary sequestration
Pulmonary valve stenosis
Pulmonic stenosis
Pure red cell aplasia
Purpura
Purpura, Schoenlein-Henoch
Purpura, thrombotic...
Pyelonephritis
Pyoderma gangrenosum
Pyomyositis
Pyrexiophobia
Pyrophobia
Pyropoikilocytosis
Pyrosis
Pyruvate kinase deficiency
Uveitis
Q
R
S
T
U
V
W
X
Y
Z
Medicines

Types of eosinophilic pneumonia

Eosinophilic pneumonia is divided into different categories depending upon whether a cause can be determined or not. Known causes include certain medications or environmental triggers, parasitic infections, and cancer. EP can also occur when the immune system attacks the lungs, a disease called Churg-Strauss syndrome. When a cause can not be found, the EP is labeled "idiopathic." Idiopathic EP can be divided into "acute eosinophilic pneumonia" (AEP) and "chronic eosinophilic pneumonia" (CEP) depending on the symptoms a person is experiencing.

Symptoms

Most causes of eosinophilic pneumonia have similar symptoms. Cough, fever, increasing breathlessness, and night sweats are prominent and almost universal. Acute eosinophilic pneumonia typically follows a rapid course. Fever and cough may develop only one or two weeks before difficulties breathing progress to the point of respiratory failure requiring mechanical ventilation. Chronic eosinophilic pneumonia usually follows a slower course. Symptoms accumulate over several months and include fevers, cough, breathlessness, wheezing, and weight loss. Individuals with CEP are often diagnosed with asthma before CEP is finally recognized.

EP due to medications or environmental exposures is similar and occurs after an exposure to a known offending agent. EP due to parasitic infections has a similar prodrome in addition to a host of different symptoms related to the variety of underlying parasites. EP in the setting of cancer often develops in the context of a known diagnosis of lung cancer, cervical cancer, etc.

Pathophysiology

Eosinophilic pneumonia can develop in several different ways depending on the underlying cause of the disease. Eosinophils are thought to play a central role in defending the body against infection by parasites. Many diseases, such as asthma and eczema, are caused when eosinophils overreact to environmental triggers and release an excess of chemicals (cytokines) such as histamine. The common characteristic among different causes of EP is eosinophil overreaction or dysfunction in the lung.

Medications and environmental exposures

Medications, drugs of abuse, and environmental exposures may all trigger eosinophil dysfunction. Medications such NSAIDs (ie ibuprofen), nitrofurantoin, phenytoin, L-tryptophan, and ampicillin and drugs of abuse such as inhaled heroin and cocaine may trigger an allergic response which results in EP. Chemicals such as sulfites, aluminum silicate, and cigarette smoke can cause EP when inhaled. A New York City firefighter developed EP after inhalation of dust from the World Trade Center on September 11, 2001.

Read more at Wikipedia.org


[List your site here Free!]


Chronic Eosinophilic Pneumonia Presenting With Recurrent Massive Bilateral Pleural Effusion - ): Case Report
From CHEST, 3/1/01 by Yaseen S. Samman

Case Report

We describe a rare case of a 29-year-old woman with chronic eosinophilic pneumonia (CEP) presenting with massive bilateral pleural effusion leading to respiratory failure, a complication that was not reported before with CEP. The patient was successfully managed with ventilatory support and steroid therapy. On long-term follow-up, she remained well, receiving a low maintenance dose of prednisone without evidence of relapse of the disease. (CHEST 2001; 119:968-970)

Key words: chronic eosinophilic pneumonia; massive pleural effusion; respiratory failure.

Abbreviations: CEP = chronic eosinophilic pneumonia; HES = hypereosinophilic syndrome

Chronic eosinophilic pneumonia (CEP), a rare eosinophilic lung disease of unknown etiology, is characterized by peripheral blood eosinophilia, chest radiograph infiltrates, and prompt response to corticosteroid therapy.[1] The first detailed description of CEP was by Carrington et al in 1969.[2]

CEP most commonly affects women of middle age. The usual symptoms are cough, dyspnea, fever, and weight loss. We report a case of CEP presenting with massive, rapidly accumulating pleural effusion progressing to respiratory failure that, to our knowledge, has not been reported previously.

CASE REPORT

A 29-year-old nonsmoking woman presented with a 5-month history of shortness of breath and dry cough. She denied any history of fever, night sweats, or weight loss. She had no history of chest pain, palpitation, arthralgia, arthritis, or skin rash. There was no neurologic or GI symptoms and no travel history.

The patient was initially admitted to another Facility with the same symptoms and received a diagnosis of bronchial asthma and bilateral exudative pleural effusions requiting frequent uncomplicated therapeutic drainage. The original reported WBC wits 10,000 cells/[micro]L with 70% eosinophils; no pulmonary function tests were performed. However, pleural analysis was reported as clear and nonhemorrhagic, with 70% lymphocytes, 1% neutrophils, and 2% eosinophils. Pleural biopsy was reported to show nonspecific inflammatory reaction consisting mainly of eosinophils.

On admission at our hospital, she was afebrile, with a respiratory rote of 25 breaths/min and decreased chest expansion. Dullness to percussion wits noted with decreased air entry at the bases. The rest of the physical examination was unremarkable. The patient was receiving salbutamol and beclomethasone inhalers from the other facility.

Results of laboratory investigations are as follows: hemoglobin, 13.9 g/dL; WBC count, 9,300 cells/[micro]L; platelets, 360,000 cells/ [micro]L; and persistent eosinophilia of 1,800 to 3,200 cells/[micro]L. Basic biochemical profile and serum immunoglobulins, including IgE were normal. Serology for locally prevalent parasites (amebiasis, echinococcosis, leishmaniasis, and schistosomiasis) by enzyme-linked immunosorbent assay method was negative. Antinuclear antibody, antimitochondrial antibody, anti-smooth muscle antibody, and anti-double-strand DNA were negative. Rheumatoid factor was weakly positive. Repeated sputum microscopy and culture and polymerase chain reaction for Mycobacterium tuberculosis results were negative. Mantoux test was negative. Stool examinations for ova and parasites (namely trichinosis, echinococcus, and schistosomiasis) were negative. Pulmonary function tests showed a severe restrictive pattern (Table 1).

[TABULAR DATA 1 NOT REPRODUCIBLE IN ASCII]

Chest radiography revealed bilateral pleural effusions with interstitial and airspace opacities in the lower third of the lungs (Fig 1). A CT scan of the chest demonstrated bilateral loculated pleural effusions; collapse and consolidation of the right lower, middle, and lingula lobes; and ground-glass opacities in the, right upper lobe (Fig 2). The pleural fluid protein was 4.3 g/dL, lactate dehydrogenase was 1,554 IU/L, and total WBC count wits 1,580 cells/[micro]L with 21% eosinophils and no abnormal cells. Pleural biopsy showed mixed inflammatory cell infiltrate with predominance of eosinophils. Echocardiographic findings were normal. Bone marrow examination showed 40% infiltration with eosinophils and a normal karyotype.

[Figures 1-2 ILLUSTRATION OMITTED]

The patient required repeated therapeutic pleural fluid drainage mitt insertion of a chest tube without clinical improvement because of rapid reaccumulation and loculation of the fluid. Respiratory failure occurred on day 3, and she required intubation and mechanical ventilation. Bronchoscopy demonstrated normal airways, and BAL revealed a WBC count of 5,100 cells/[micro]L with 80% eosinophils and a negative culture finding.

On the basis of the persistent peripheral eosinophilia, infiltrates on chest radiography, eosinophilic pleural effusion, high percentage of eosinophils in the BAL, and negative investigations for other causes of eosinophilia, the diagnosis of CEP was made.

The patient responded rapidly to treatment with IV methylprednisolone, 1 g/d; 3 days later, she was successfully extubated. Her treatment was changed to oral prednisolone, 40 mg/d, and she was discharged on the eighth hospital day.

On follow-up visits, the patient remained asymptomatic, and the prednisolone was tapered to 15 mg/d by 6 months and was stopped by 9 months, with chest radiography showing residual bilateral pleural thickening, and significant improvement on pulmonary function testing (Table 1). On follow-up, there was no relapse 4 months after discontinuation of steroid therapy.

DISCUSSION

Our patient satisfied the criteria for the diagnosis of CEP.[1] Pulmonary involvement may occur in 40% of patients with idiopathic hypereosinophilic syndrome (HES) and may therefore closely resemble CEP.[1,3] However, because of the absence of multiorgan involvement with signs of end-organ damage, one of the triad of HES,[3] and the characteristic radiologic findings of CEP in our patient, the diagnosis of HES was excluded. Bronchiolitis obliterans with organizing pneumonia may also mimic CEP, but the radiologic and BAL findings were incompatible with the diagnosis of bronchiolitis obliterans with organizing pneumonia.[1]

The onset of CEP is usually insidious, and symptoms are present for at least a few months before diagnosis, as in our patient. If the diagnosis is delayed, progression to respiratory failure may occur.[1] Bronchial asthma is present in about half of the cases.[4] Peripheral eosinophilia occurs in most patients with CEP and may be associated width elevated IgE levels. The latter may parallel the disease activity.[1] In 25% of patients with CEP, chest radiography shows the characteristic, extensive bilateral peripheral infiltrates, described as a photographic negative image of pulmonary edema.[5] This was not present in our patient.

Pleural effusion is uncommon in CEP. In a review of 19 cases of CEP, only 2 patients had pleural effusion, and in a multicenter study, 2 of 62 patients had bilateral small-size pleural effusions.[4,6] The mechanism of pleural effusion in CEP is unknown. However, it might be because of tissue damage induced by infiltration with eosinophils, antibody-mediated cellular toxicity, or the release of intracytoplasmic leukotriene that increases microvascular permeability.[1]

Our patient had severe restrictive lung disease, as reported in the majority of patients with CEP.[1] Durieu et al[7] found that 9 of 19 patients with CEP had restrictive abnormalities and 4 patients had obstructive abnormalities, and on long-term follow-up, 8 of the 19 patients showed complete recovery. The high diffusion capacity of the lung for carbon monoxide/alveolar volume ratio in our patient could be explained, initially, by the large pleural effusion, collapse and entrapment of the lungs, and, lately, by pleural thickening.[7-9]

Open lung biopsy is performed when the diagnosis is in doubt,[1] and this usually shows interstitial and alveolar infiltration with eosinophils, microabscesses, Charcot-Leyden crystals, and bronchiolitis obliterans. The prompt response to corticosteroids, as seen in our patient, is characteristic in CEP.[1] The prognosis of CEP is excellent, but there may be relapse of disease. Therefore, decreasing doses of corticosteroids are recommended for at least 6 to 19 months.[1]

CONCLUSION

Although not reported before, rapidly accumulating pleural effusions could be a presenting feature of CEP. Early recognition of this is important in view of the good response to treatment with corticosteroids.

REFERENCES

[1] Allen JN, Davis WB. Eosinophilic lung diseases. Am J Respir Crit Care Med 1994; 150:1423-1438

[2] Carrington CB, Addington, WW, Goff, AM, et al. Chronic eosinophilic pneumonia. N Engl J Med 1969; 980:787-798

[3] Fauci AS, Harley JB, Roberts WC, et al. The idiopathic hyperoesinophilic syndrome: clinical, pathophysiologic, and therapeutic considerations. Ann Intern Med 1982; 97:78-92

[4] Marchand E, Reynand-Gaubert M, Lauque D, et al. Idiopathic chronic eosinophilia pneumonia: a clinical and follow-up study of 62 cases. Medicine 1998; 77:299-312

[5] Gaensler EA, Carrington CB. Peripheral opacities in chronic eosinophilic pneumonia: the photographic negative of pulmonary edema. AJR Am J Roentgenol 1977; 128:1-13

[6] Jederlinic PJ, Sicilian L, Gaensler EA. Chronic eosinophilic pneumonia: a report of 19 cases and a review of the literature. Medicine 1988; 67:154-162

[7] Durieu J, Wallaert B, Tonnel AB. Long term follow-up of pulmonary function in chronic eosinophilic pneumonia. Eur Respir J 1997; 10:286-291

[8] Seigler D, Zorab PA. The influence of lung volume on gas transfer in scoliosis. Br J Dis Chest 1982; 76:44-50

[9] Miller A. Pulmonary function tests in clinical and occupational lung disease. Orlando, FL: Grune and Stratton, 1986; 147-148

(*) From the Department of Medicine, King Khalid National Guard Hospital, Jeddah, Saudi Arabia.

Manuscript received November 23, 1999; revision accepted August 15, 2000.

Correspondence to: Yaseen S. Samman, MD, FCCP, Department of Medicine, King Khalid National Guard Hospital, PO Box 9515, Jeddah 21423, Saudi Arabia; e-mail: Sammanys@ngha.med.sa

COPYRIGHT 2001 American College of Chest Physicians
COPYRIGHT 2001 Gale Group

Return to Pneumonia, eosinophilic
Home Contact Resources Exchange Links ebay